Cargando…
Postvaccine Anti–SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients
Autores principales: | Husain, Syed Ali, Tsapepas, Demetra, Paget, Kathryn F., Chang, Jae-Hyung, Crew, R. John, Dube, Geoffrey K., Fernandez, Hilda E., Morris, Heather K., Mohan, Sumit, Cohen, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062410/ https://www.ncbi.nlm.nih.gov/pubmed/33907723 http://dx.doi.org/10.1016/j.ekir.2021.04.017 |
Ejemplares similares
-
Clinically Significant COVID-19 Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients
por: Tsapepas, Demetra, et al.
Publicado: (2021) -
Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
por: Leal, Rita, et al.
Publicado: (2017) -
COVID-19 Severity in Kidney Transplant Recipients According to Their Postvaccination Serological Assessment
por: Masset, Christophe, et al.
Publicado: (2022) -
Association Between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant
por: Husain, S. Ali, et al.
Publicado: (2021) -
Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019)